AVK-21

AVK-21: Levonorgestrel IP 0.15 mg + Ethinylestradiol IP 0.03 mg tablets (Blister) for oral contraception and managing menstrual-related disorders.

Category:
Add to Wishlist
Add to Wishlist

Description

  • Active Ingredients:
    • Levonorgestrel IP 0.15 mg: A synthetic progestogen that helps prevent ovulation.
    • Ethinylestradiol IP 0.03 mg: A synthetic estrogen that regulates the menstrual cycle.
  • Indications:
    • Oral contraception (birth control)
    • Regulation of menstrual cycles
    • Management of menstrual-related disorders (e.g., dysmenorrhea, premenstrual syndrome)
    • Reduction of menstrual bleeding
  • Mechanism of Action: The combination of levonorgestrel and ethinylestradiol works by inhibiting ovulation, altering the cervical mucus to prevent sperm penetration, and modifying the endometrial lining to prevent implantation of a fertilized egg.
  • Benefits:
    • Highly effective in preventing pregnancy when taken as directed.
    • Helps regulate menstrual cycles and reduce menstrual-related symptoms.
    • Reduces the risk of ovarian cysts and certain types of cancers.
    • Provides convenience and ease of use with once-daily dosing.
  • Precautions: Not recommended for individuals with a known hypersensitivity to levonorgestrel, ethinylestradiol, or any other components of the formulation. Contraindicated in women with a history of thromboembolic disorders, stroke, severe liver disease, breast cancer, or unexplained vaginal bleeding. Smoking increases the risk of serious cardiovascular side effects, especially in women over 35 years of age. Consult a healthcare provider before using during pregnancy or breastfeeding.

Reviews

There are no reviews yet.

Be the first to review “AVK-21”

Your email address will not be published. Required fields are marked *

ENQUIRE FORM